Patent law

Purchasers of Allied Nevada Gold Corporation Common Stock may be Affected by Proposed Class Action Settlement Announces Brower Piven

Retrieved on: 
Wednesday, July 22, 2020
Patent claim, Patent law

IF YOU PURCHASED OR ACQUIRED ALLIED COMMON STOCK IN THE UNITED STATES OR ON A SECURITIES EXCHANGE IN THE UNITED STATESFROM JANUARY 18, 2013, THROUGH AND INCLUDING AUGUST 5, 2013, YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS LITIGATION.

Key Points: 
  • IF YOU PURCHASED OR ACQUIRED ALLIED COMMON STOCK IN THE UNITED STATES OR ON A SECURITIES EXCHANGE IN THE UNITED STATESFROM JANUARY 18, 2013, THROUGH AND INCLUDING AUGUST 5, 2013, YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS LITIGATION.
  • To share in the distribution of the Settlement Fund, you must establish your rights by submitting a Proof of Claim and Release form ("Proof of Claim") by mail postmarked no later than November 7, 2020 or electronically submitted online no later than November 7, 2020.
  • Your failure to submit or deliver your Proof of Claim form by November 7, 2020, will subject your claim to rejection and preclude your receiving any of the recovery in connection with the Settlement of this Litigation.
  • Inquiries, other than requests for the Notice or for a Proof of Claim form, may be made to Lead Counsel:

Sonasoft (SSFT) Reports Full-Year 2019 Audited Revenue of $13.33 Million; an Increase of 1260% YoY; First Quarter 2020 Revenue of $2.8 Million; an Increase of 47% YoY

Retrieved on: 
Wednesday, July 22, 2020
Articles, Science and technology, Academic disciplines, Computational neuroscience, Expense, Intellectual property law, Patent law, Royalty payment, Artificial intelligence

Sonasoft Corp. generated audited full-year 2019 revenue of $13.33M, an increase of $12.35M over its 2018 full-year result.

Key Points: 
  • Sonasoft Corp. generated audited full-year 2019 revenue of $13.33M, an increase of $12.35M over its 2018 full-year result.
  • Excluding stock-based compensation and accruals for royalties, this loss reduces to $3.2M, a $1.7M increase over 2018 result.
  • Inc. contributed approximately $10.6M in revenue, E-Connect approximately $2.2M (over 7 months), Sonavault approximately $0.5M, and Sona-AI less than $0.1M (over 9 months).
  • Sonasoft NuGene is a unified AI platform that can process any type of data and generate autonomous AI models.

The Supreme People’s Court Ruled That HISKY Has Won the Patent Infringement Case, and Confirmed That HISKY Did Not Commitment Infringement

Retrieved on: 
Wednesday, July 22, 2020
Medical devices, Health, Patent law

According to the verdict, the key to this case is the patent of Imaging Method and Device Using Shear Waves held by SEISME.

Key Points: 
  • According to the verdict, the key to this case is the patent of Imaging Method and Device Using Shear Waves held by SEISME.
  • Echosens subsidiary company, SEISME eventually lost the case, as ruled by the Supreme Peoples Court.
  • According to the final judgment made by the Supreme Peoples Court, the technical features of HISKY products are neither identical with nor equivalent to those of such patent.
  • The disputed patent adopted the technical solution of simultaneous observation + full receiving , while HISKY products adopted the technical solution of delayed observation + partial receiving.

Nationwide Election for Inventor Representative to Patent Public Advisory Committee

Retrieved on: 
Wednesday, July 22, 2020
Intellectual property law, Patent law, Intellectual property organizations, Patent offices, United States Patent and Trademark Office, United States trademark law, PPAC, Inventor

ALEXANDRIA, Va., July 21, 2020 /PRNewswire/ -- US Inventor, a non-profit organization that advocates for the rights of inventors, is hosting an election to choose one or more delegates to sit on the Patent Public Advisory Committee (PPAC).

Key Points: 
  • ALEXANDRIA, Va., July 21, 2020 /PRNewswire/ -- US Inventor, a non-profit organization that advocates for the rights of inventors, is hosting an election to choose one or more delegates to sit on the Patent Public Advisory Committee (PPAC).
  • The PPAC is an official committee created by the U.S. Congress and charged with reviewing operations of the USPTO and advising the Director of the USPTO.
  • The 1999 law requires the Secretary of Commerce to appoint the 9 members of the committee, including at least one independent inventor.
  • With these concerns in view, US Inventor is hosting this election to provide an opportunity for inventors and their supporters to choose their representative on the PPAC.

Kajeet Shares Updates on its Patent Licensing Program Aimed at Providing Safe, Reliable Internet to Students Everywhere

Retrieved on: 
Tuesday, July 21, 2020
Patent law, Monopoly, Kajeet, Patent, License, Business

During this time of COVID-19 these innovations are proving to be highly desirable as students and employees study and work from home.

Key Points: 
  • During this time of COVID-19 these innovations are proving to be highly desirable as students and employees study and work from home.
  • To achieve this, Kajeet's founders and engineers have developed a patent portfolio of 36 issued U.S. patents and pending applications.
  • Recently Kajeet has embarked on a patent licensing strategy to level the competitive market place and help make its innovations available to anyone that needs them.
  • Kajeet is being advised by Patent Monetization Inc. and its legal representative is the law firm Friedman Suder & Cooke.

Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12

Retrieved on: 
Monday, July 20, 2020
Expense, Intellectual property law, Patent law, Royalty payment

NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (NASDAQ: RPRX) today announced that it will report its second quarter 2020 financial results onWednesday, August 12, 2020, before the U.S. financial markets open.

Key Points: 
  • NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (NASDAQ: RPRX) today announced that it will report its second quarter 2020 financial results onWednesday, August 12, 2020, before the U.S. financial markets open.
  • The Company will host a conference call and simultaneous webcast at8:00 AM Eastern Timethat day.
  • The dial in number to join the call is (833) 519-1253 from within the United States; the number for international callers is + 1 (914) 800-3826.
  • Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industrys leading therapies.

InventHelp Inventor Develops Accessory to Keep Shirts Neatly Tucked (MTN-3460)

Retrieved on: 
Monday, July 20, 2020
Patent law, Human behavior, Creativity, Invention, Science, Inventor, Humans, Articles

The invention ensures that a shirt remains securely tucked into pants.

Key Points: 
  • The invention ensures that a shirt remains securely tucked into pants.
  • As a result, it eliminates the need to repeatedly tuck in a shirt and it provides a neat appearance.
  • The inventor described the invention design.
  • The original design was submitted to the Manhattan sales office of InventHelp.

Smart Monitor Awarded U.S. Patent for Systems to Detect Motion Disorders, Including Seizures and Epilepsy

Retrieved on: 
Monday, July 20, 2020
Epileptic seizure, RTT, Epilepsy, Patent law, Health, Branches of biology, United States patent law, Articles

SAN JOSE, Calif., July 20, 2020 /PRNewswire-PRWeb/ --Smart Monitor, the leading provider of clinically validated solutions for managing epilepsy and other chronic conditions, announced that the United States Patent and Trademark Office awarded United States Patent Number 10,595,766, entitled"Abnormal Motion Detector and Monitor," to Smart Monitor ('766 Patent).

Key Points: 
  • SAN JOSE, Calif., July 20, 2020 /PRNewswire-PRWeb/ --Smart Monitor, the leading provider of clinically validated solutions for managing epilepsy and other chronic conditions, announced that the United States Patent and Trademark Office awarded United States Patent Number 10,595,766, entitled"Abnormal Motion Detector and Monitor," to Smart Monitor ('766 Patent).
  • The '766 Patent covers technology for detecting motion related disorders, including seizures and epilepsy.
  • The '766 Patent belongs to a family of patents that includes United States Patent Number 8,075,499 of Smart Monitor.
  • This patent family concerns Smart Monitor's proprietary technology for providing intelligent detection, monitoring, and alerting of seizures and other conditions.

IPValue Management Affiliate Licenses RPX Clients

Retrieved on: 
Monday, July 20, 2020
Technology, Hardware, Semiconductor, RPX Corporation, Patent law, RPX, Patent portfolio

IPValue Management, Inc. (IPValue) today announced that its wholly owned subsidiary Pannova Semic, LLC (Pannova) has completed an agreement with RPX Corporation (RPX) for a worldwide, nonexclusive license to Pannovas patent portfolio for a number of RPX clients.

Key Points: 
  • IPValue Management, Inc. (IPValue) today announced that its wholly owned subsidiary Pannova Semic, LLC (Pannova) has completed an agreement with RPX Corporation (RPX) for a worldwide, nonexclusive license to Pannovas patent portfolio for a number of RPX clients.
  • We are pleased to have had productive negotiations with RPX, leading to a suitable and amicable resolution for a number of their clients, said Warren Waskiewicz, General Manager of Pannova.
  • Since inception in 2001, IPValue has generated over $2B in cash from patent licenses, resulting in $1B to its partners.
  • IPValue currently owns and manages the commercialization of over 7,000 patents.

Claren Energy to Divest of the Bobocu Production License in Romania

Retrieved on: 
Thursday, July 16, 2020
Expense, Intellectual property law, Patent law, Royalty payment, Natural gas

In consideration of which, Lalea will grant Claren an Overriding Royalty of 5% on produced gas during the economic field life of Bobocu.

Key Points: 
  • In consideration of which, Lalea will grant Claren an Overriding Royalty of 5% on produced gas during the economic field life of Bobocu.
  • We are pleased with Laleas commitment to develop the Bobocu gas field, stated Henry Aldorf, Clarens Chairman and CEO.
  • Claren and its shareholders will be able to participate in the upside of any gas production via our overriding royalty.
  • Claren Energy Corp. is an oil and gas company that has a (100%) participating interest in the Bobocu Production License, onshore Romania.